Carlos Campoy - 16 Mar 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
Chief Financial Officer
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Carlos Campoy
Issuer symbol
CTMX
Transactions as of
16 Mar 2023
Net transactions value
-$3,459
Form type
4
Filing time
20 Mar 2023, 18:43:33 UTC
Previous filing
21 Jul 2022
Next filing
30 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $3,459 -1,748 -4.4% $1.98 38,224 16 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 16,875 restricted stock units.